Stanley Druckenmiller’s Eli Lilly LLY Stock Holding History

Stanley Druckenmiller’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-100,675	Closed	-$78.5M	–	90
2025 Q2	$78.5M	Buy	100,675 +5,845	+6%	+$4.54M	1.93%	16
2025 Q1	$78.3M	Buy	94,830 +32,640	+52%	+$27.2M	2.56%	12
2024 Q4	$48M	Buy	+62,190	New	+$51.5M	1.29%	20
2024 Q2	–	Sell	-61,664	Closed	-$48M	–	77
2024 Q1	$48M	Sell	61,664 -340,886	-85%	-$243M	1.09%	23
2023 Q4	$235M	Sell	402,550 -51,565	-11%	-$30.1M	7%	5
2023 Q3	$244M	Sell	454,115 -82,330	-15%	-$42.4M	8.75%	4
2023 Q2	$252M	Sell	536,445 -69,765	-12%	-$29.3M	8.75%	4
2023 Q1	$208M	Sell	606,210 -131,515	-18%	-$44.4M	9.02%	4
2022 Q4	$270M	Buy	737,725 +252,830	+52%	+$89.6M	13.36%	2
2022 Q3	$157M	Buy	484,895 +187,745	+63%	+$59.5M	8.89%	2
2022 Q2	$96.3M	Buy	+297,150	New	+$89.2M	6.97%	4

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Stanley Druckenmiller's LLY Position: Q3 2025 in Review

Stanley Druckenmiller sold out of Eli Lilly (LLY) in Q3 2025, closing a stake of 100,675 shares — an estimated $78.5M sold.

Stanley Druckenmiller first reported a position in LLY in Q2 2022 and held it in 11 quarters. The position peaked at $270M in Q4 2022. 3,898 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

Stanley Druckenmiller reported no remaining Eli Lilly position as of Q3 2025 after selling out during the quarter.
Stanley Druckenmiller sold 100,675 Eli Lilly shares in Q3 2025, an estimated $78.5M.
Stanley Druckenmiller first reported a position in Eli Lilly in Q2 2022 and held it in 11 quarters.
Stanley Druckenmiller's Eli Lilly position peaked at $270M in Q4 2022.
3,898 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Duquesne Family Office's 13F filing for Q3 2025, filed 14 Nov 2025.